Chromophobe renal cell carcinoma: A comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray

Histopathology

Volumn 45, Issue 6, 2004, Pages 593-602

  Abrahams, N A ^a,f   MacLennan, G T ^b   Khoury, J D ^b   Ormsby, A H ^a   Tamboli, P ^d   Doglioni, C ^e   Schumacher, B ^a   Tickoo, S K ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e SAN MARTINO HOSPITAL   (Italy)

^f UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Chromophobe renal cell carcinoma; Immunohistochemistry; Microarray; Parvalbumin

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; EPITHELIAL MEMBRANE ANTIGEN; FERRIC HYDROXIDE; KERATIN; MITOCHONDRION ANTIBODY; PARVALBUMIN; TUMOR MARKER; VIMENTIN;

ARTICLE; BIOASSAY; CANCER DIAGNOSIS; CELL ULTRASTRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; ELECTRON MICROSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; PATHOLOGIST; PRIORITY JOURNAL; TISSUE MICROARRAY;

ADENOMA, OXYPHILIC; CA-15-3 ANTIGEN; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; KERATIN-7; KERATINS; KIDNEY NEOPLASMS; MICROSCOPY, ELECTRON; NEPRILYSIN; OBSERVER VARIATION; PARVALBUMINS; PATHOLOGY, CLINICAL; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; TISSUE ARRAY ANALYSIS; VIMENTIN;

EID: 11144295756     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2004.02003.x     Document Type: Article

References (31)

1. Thoenes W, Storkel S, Rumpelt HJ. Human chromophobe cell renal carcinoma. Virchows Arch. B Cell. Pathol. Ind. Mol. Pathol. 1985; 48; 207-217.
2. Thoenes W, Storkel S, Rumpelt HJ et al. Chromophobe cell renal carcinoma and its variants - a report on 32 cases. J. Pathol. 1988; 155; 277-287.
3. Amin MB, Tamboli P, Javidan J et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am. J. Surg. Pathol. 2002; 26; 281-291.
4. Moch H, Gasser T, Amin MB et al. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer 2000; 89; 604-614.
5. Tickoo SK, Amin MB. Discriminant nuclear features of renal oncocytoma and chromophobe renal cell carcinoma. Analysis of their potential utility in the differential diagnosis. Am. J. Clin. Pathol. 1998; 110; 782-787.
6. Amin MB, Crotty TB, Tickoo SK et al. Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases. Am. J. Surg. Pathol. 1997; 21; 1-12.
7. Cochand-Priollet B, Molinie V, Bougaran J et al. Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases. Arch. Pathol. Lab. Med. 1997; 121; 1081-1086.
8. Perez-Ordonez B, Hamed G, Campbell S et al. Renal oncocytoma: a clinicopathologic study of 70 cases. Am. J. Surg. Pathol. 1997; 21; 871-883.
9. Avery AK, Beckstead J, Renshaw AA et al. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am. J. Surg. Pathol. 2000; 24; 203-210.
10. Khoury JD, Abrahams NA, Levin HS et al. The utility of epithelial membrane antigen and vimentin in the diagnosis of chromophobe renal cell carcinoma. Ann. Diagn. Pathol. 2002; 6; 154-158.
11. Kuroda N, Inoue K, Guo L et al. Expression of CD9 / motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas. Hum. Pathol. 2001; 32; 1071-1077.
12. Wu SL, Kothari P, Wheeler TM et al. Cytokeratins 7 and 20 immunoreactivity in chromophobe renal cell carcinomas and renal oncocytomas. Mod. Pathol. 2002; 15; 712-717.
13. Tickoo SK, Amin MB, Linden MD et al. Antimitochondrial antibody (113-1) in the differential diagnosis of granular renal cell tumors. Am. J. Surg. Pathol. 1997; 21; 922-930.
14. Tickoo SK, Amin MB. Zarbo RJ. Colloidal iron staining in renal epithelial neoplasms, including chromophobe renal cell carcinoma: emphasis on technique and patterns of staining. Am. J. Surg. Pathol. 1998; 22; 419-424.
15. Stopyra GA, Warhol MJ, Multhaupt HA. Cytokeratin 20 immunoreactivity in renal oncocytomas. J. Histochem. Cytochem. 2001; 49; 919-920.
16. McGregor DK, Khurana KK, Cao C et al. Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody 'Renal Cell Carcinoma Marker'. Am. J. Surg. Pathol. 2001; 25; 1485-1492.
17. Mathers ME, Pollock AM, Marsh C et al. Cytokeratin 7: a useful adjunct in the diagnosis of chromophobe renal cell carcinoma. Histopathology 2002; 40; 563-567.
18. Martignoni G, Pea M, Chilosi M et al. Parvalbumin is constantly expressed in chromophobe renal carcinoma. Mod. Pathol. 2001; 14; 760-767.
19. MacLennan GT, Farrow G, Bostwick DG. Immunohistochemistry in the evaluation of renal cell carcinoma: a critical appraisal. J. Urol. Pathol. 1997; 6; 195-203.
20. Kononen J, Bubendorf L, Kallioniemi A et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 1998; 4; 844-847.
21. Hoos A, Urist MJ, Stojadinovic A et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am. J. Pathol. 2001; 158; 1245-1251.
22. Erlandson RA, Shek TW, Reuter VE. Diagnostic significance of mitochondria in four types of renal epithelial neoplasms: an ultrastructural study of 60 tumors. Ultrastruct. Pathol. 1997; 21; 409-417.
23. Gerharz CD, Moll R, Storkel S et al. Ultrastructural appearance and cytoskeletal architecture of the clear, chromophilic, and chromophobe types of human renal cell carcinoma in vitro. Am. J. Pathol. 1993; 142; 851-859.
24. Tickoo SK, Lee MW, Eble JN et al. Ultrastructural observations on mitochondria and microvesicles in renal oncocytoma, chromophobe renal cell carcinoma, and eosinophilic variant of conventional (clear cell) renal cell carcinoma. Am. J. Surg. Pathol. 2000; 24; 1247-1256.
25. Krishnan B, Truong LD. Renal epithelial neoplasms: the diagnostic implications of electron microscopic study in 55 cases. Hum. Pathol. 2002; 33; 68-79.
26. Kovacs G, Akhtar M, Beckwith BJ et al. The Heidelberg classification of renal cell tumours. J. Pathol. 1997; 183; 131-133.
27. Ljungberg B, Alamdari FI, Stenling R et al. Prognostic significance of the Heidelberg classification of renal cell carcinoma. Eur. Urol. 1999; 36; 565-569.
28. Onishi T, Oishi Y, Yanada S et al. Prognostic implications of histological features in patients with chromophobe cell renal carcinoma. BJU Int. 2002; 90; 529-532.
29. Bonsib SM, Bray C, Timmerman TG. Renal chromophobe cell carcinoma: limitations of paraffin-embedded tissue. Ultrastruct Pathol. 1993; 17; 529-536.
30. Leroy X, Moukassa D, Copin MC et al. Utility of cytokeratin 7 for distinguishing chromophobe renal cell carcinoma from renal oncocytoma. Eur. Urol. 2000; 37; 484-487.
31. Chu P, Arber DA. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am. J. Clin. Pathol. 2000; 113; 374-382.